Publications by authors named "Mariangela Desantis"
Article Synopsis
- Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) show a low mortality rate of 1% and a 12.5% rate of severe adverse events in patients with peritoneal carcinomatosis, indicating it is a viable treatment option.
- Major factors influencing overall survival include the type of cancer (with peritoneal mesothelioma patients showing the best survival rates), performance status, and surgical details like operating time and number of procedures performed.
- The study suggests that the acceptable risk of complications in CRS and HIPEC is worthwhile when considering the potential for increased survival in carefully selected patients at specialized medical centers.
Objective: To investigate the benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of endometrial peritoneal carcinomatosis.
Study Design: Preoperative, intraoperative and postoperative data were collected prospectively for 13 patients treated in our University hospital.
Results: Of the thirteen patients treated, one patient was lost to follow up.